Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
drugs
2
×
life sciences
2
×
national blog main
new york blog main
2
×
achaogen
adams street partners
alirocumab
alnylam pharmaceuticals
amgen
antibiotics
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston blog main
deals
drug resistance
evercore isi
evolocumab
fda
hatteras venture partners
heart attack
inclisiran
investing
joseph swartz
lyzz capital
macrolide pharmaceuticals
medicines co.
melinta therapeutics
meropenem
michael dudley
new enterprise associates
new york
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rempex pharmaceuticals
rna interference
san diego
san diego blog main
What
drug
medicines
2
×
alnylam
bacteria
based
biopharma
business
cholesterol
company
data
disease
evidence
exited
fighting
heart
infections
infectious
lasting
launches
long
looms
lowering
medco
melinta
new
partner
pharmaceuticals
presented
products
qpex
reckoning
resistant
rna
sold
supporting
tackle
term
therapeutics
touts
use
Language
Current search:
medicines
×
biotech
×
" life sciences "
×
drugs
×
" new york blog main "
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
